STRASBOURG, France & TOKYO & WALTHAM, Mass.–(BUSINESS WIRE)– #TG4050–Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, NEC Corporation (NEC; TSE: 6701), a leader in IT and network technologies and BostonGene Corporation (BostonGene), a biomedical software company committed to defining optimal precision medicine-based therapies for cancer patients, today announced a strategic collaboration for two ongoi
Welcome! Log into your account
Recover your password
A password will be e-mailed to you.